182 related articles for article (PubMed ID: 6605026)
1. Dissociation of natural killer activity and antibody-dependent cellular cytotoxicity in spleen cells of tumor bearing mice.
Ono M; Tanaka N; Orita K
Acta Med Okayama; 1983 Aug; 37(4):367-76. PubMed ID: 6605026
[TBL] [Abstract][Full Text] [Related]
2. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
Kawase I; Komuta K; Hara H; Inoue T; Hosoe S; Ikeda T; Shirasaka T; Yokota S; Tanio Y; Masuno T
Cancer Res; 1988 Mar; 48(5):1173-9. PubMed ID: 3257715
[TBL] [Abstract][Full Text] [Related]
3. NK cells from mammary tumor bearing mice do not exert natural killer activity but function as antibody dependent cellular cytotoxicity effectors.
Rivera LM; Lopez DM
Anticancer Res; 1993; 13(1):177-84. PubMed ID: 8476211
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of murine non-specific killer cells induced in vivo by recombinant human interleukin-2.
Hinuma S; Naruo K; Shiho O; Tsukamoto K
Immunology; 1986 Oct; 59(2):251-9. PubMed ID: 3490435
[TBL] [Abstract][Full Text] [Related]
5. Identification and separation of Thy-1 positive mouse spleen cells active in natural cytotoxicity and antibody-dependent cell-mediated cytotoxicity.
Mattes MJ; Sharrow SO; Herberman RB; Holden HT
J Immunol; 1979 Dec; 123(6):2851-60. PubMed ID: 387876
[TBL] [Abstract][Full Text] [Related]
6. Host reactivity against clonable tumor cells and the total tumor cell population, studied in a syngeneic murine lymphoma system.
Gjedde SB
Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):101-8. PubMed ID: 6349250
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of effector cell functions in natural killer cell activity (NK) and antibody-dependent cellular cytotoxicity (ADCC) in mice by normal and cancer sera.
Nair PN; Fernandes G; Onoe K; Day NK; Good RA
Int J Cancer; 1980 May; 25(5):667-77. PubMed ID: 7372374
[No Abstract] [Full Text] [Related]
8. Antibody-induced augmentation of murine natural killer cell activity.
Brunda MJ; Herberman RB; Holden HT
Int J Cancer; 1981 Feb; 27(2):205-11. PubMed ID: 7287215
[TBL] [Abstract][Full Text] [Related]
9. Early appearance and activation of natural killer cells in tumor-infiltrating lymphoid cells during tumor development.
Kurosawa S; Matsuzaki G; Harada M; Ando T; Nomoto K
Eur J Immunol; 1993 May; 23(5):1029-33. PubMed ID: 8477798
[TBL] [Abstract][Full Text] [Related]
10. Activation of NK activity and auto-reactive cytotoxicity after hepatectomy.
Ono M; Tanaka N; Orita K
Acta Med Okayama; 1984 Apr; 38(2):207-13. PubMed ID: 6610280
[TBL] [Abstract][Full Text] [Related]
11. Modulation of cytotoxic T lymphocyte, natural killer cell, antibody-dependent cellular cytotoxicity, and antibody-dependent complement-mediated cytotoxicity by Vernonia cinerea L. and vernolide-A in BALB/c mice via enhanced production of cytokines IL-2 and IFN-γ.
Pratheeshkumar P; Kuttan G
Immunopharmacol Immunotoxicol; 2012 Feb; 34(1):46-55. PubMed ID: 22176676
[TBL] [Abstract][Full Text] [Related]
12. Suppression of alloimmune cytotoxic T lymphocyte (CTL) generation by depletion of NK cells and restoration by interferon and/or interleukin 2.
Suzuki R; Suzuki S; Ebina N; Kumagai K
J Immunol; 1985 Apr; 134(4):2139-48. PubMed ID: 2579129
[TBL] [Abstract][Full Text] [Related]
13. [Effect of NK-421 (Bestatin) and Ge-132 on the cytotoxicity of spleen cells obtained from the tumor-bearing mice].
Ono M; Oka T; Yoshihara H; Tanaka N; Miwa H; Mannami T; Konaga E; Orita K
Gan To Kagaku Ryoho; 1982 Oct; 9(10):1771-7. PubMed ID: 7184374
[TBL] [Abstract][Full Text] [Related]
14. Murine T cells that lyse antibody-sensitized target cells. III. Contribution of Thy 1-Bearing cells to the lytic activity of normal spleen.
Lamon EW; Pollok BA; Walia AS; Fuson EW; Williams B
Immunology; 1981 Aug; 43(4):643-51. PubMed ID: 6974130
[TBL] [Abstract][Full Text] [Related]
15. Regressor serum factor-dependent nonspecific killers in tumor-bearing mice.
Tanino T; Egawa K
Jpn J Exp Med; 1986 Aug; 56(4):163-8. PubMed ID: 3820734
[TBL] [Abstract][Full Text] [Related]
16. Correlation between natural and antibody-dependent cell-mediated cytotoxicity against tumor targets in the mouse. II. Characterization of the effector cells.
Santoni A; Herberman RB; Holden HT
J Natl Cancer Inst; 1979 Oct; 63(4):995-1003. PubMed ID: 384012
[TBL] [Abstract][Full Text] [Related]
17. Studies of the thymus in mice bearing the Lewis lung carcinoma. I. Thymic natural killer cell activity in 3LL tumor-bearing mice.
Kaiserlian D; Savino W; Bach JF
Cell Immunol; 1983 Aug; 80(1):187-97. PubMed ID: 6872007
[TBL] [Abstract][Full Text] [Related]
18. Murine tumor cell lysis by antibody-dependent macrophage-mediated cytotoxicity using syngeneic monoclonal antibodies.
Kawase I; Komuta K; Ogura T; Fujiwara H; Hamaoka T; Kishimoto S
Cancer Res; 1985 Apr; 45(4):1663-8. PubMed ID: 3978634
[TBL] [Abstract][Full Text] [Related]
19. Enhanced tumor growth and metastatic spread of an MH134 variant lacking a part of the MM antigen: a possible role of antibody-dependent cellular cytotoxicity in control of tumor growth and metastases.
Hara H; Kawase I; Komuta K; Masuno T; Kishimoto S
Int J Cancer; 1989 Jul; 44(1):137-42. PubMed ID: 2744883
[TBL] [Abstract][Full Text] [Related]
20. Expansion of natural killer cells in mice transgenic for IgM antibody to ganglioside GD2: demonstration of prolonged survival after challenge with syngeneic tumor cells.
Kawashima I; Yoshida Y; Taya C; Shitara H; Yonekawa H; Karasuyama H; Tada N; Furukawa K; Tai T
Int J Oncol; 2003 Aug; 23(2):381-8. PubMed ID: 12851687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
